Compressing drug development timelines in oncology using phase '0' trials.

MLA

Kummar, Shivaani, et al. “Compressing Drug Development Timelines in Oncology Using Phase ‘0’ Trials.” Nature Reviews Cancer, vol. 7, no. 2, Feb. 2007, pp. 131–39. EBSCOhost, https://doi.org/10.1038/nrc2066.

APA

Kummar, S., Kinders, R., Rubinstein, L., Parchment, R. E., Murgo, A. J., Collins, J., Pickeral, O., Low, J., Steinberg, S. M., Gutierrez, M., Yang, S., Helman, L., Wiltrout, R., Tomaszewski, J. E., & Doroshow, J. H. (2007). Compressing drug development timelines in oncology using phase “0” trials. Nature Reviews Cancer, 7(2), 131–139. https://doi.org/10.1038/nrc2066

Chicago

Kummar, Shivaani, Robert Kinders, Larry Rubinstein, Ralph E. Parchment, Anthony J. Murgo, Jerry Collins, Oxana Pickeral, et al. 2007. “Compressing Drug Development Timelines in Oncology Using Phase ‘0’ Trials.” Nature Reviews Cancer 7 (2): 131–39. doi:10.1038/nrc2066.